INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 109 filers reported holding INTERSECT ENT INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $680,000 | -61.2% | 40,000 | -48.1% | 0.01% | -62.5% |
| Q2 2019 | $1,753,000 | -29.2% | 77,000 | 0.0% | 0.02% | -23.8% |
| Q1 2019 | $2,476,000 | -12.1% | 77,000 | -23.0% | 0.02% | -16.0% |
| Q4 2018 | $2,818,000 | -2.0% | 100,000 | 0.0% | 0.02% | +25.0% |
| Q3 2018 | $2,875,000 | +195.2% | 100,000 | +284.6% | 0.02% | +185.7% |
| Q2 2018 | $974,000 | -70.8% | 26,000 | -69.4% | 0.01% | -69.6% |
| Q1 2018 | $3,340,000 | +9.7% | 85,000 | -9.6% | 0.02% | +15.0% |
| Q4 2017 | $3,046,000 | +4.0% | 94,000 | 0.0% | 0.02% | +5.3% |
| Q3 2017 | $2,928,000 | +11.5% | 94,000 | 0.0% | 0.02% | +11.8% |
| Q2 2017 | $2,627,000 | +63.0% | 94,000 | 0.0% | 0.02% | +54.5% |
| Q1 2017 | $1,612,000 | -52.6% | 94,000 | -66.5% | 0.01% | -50.0% |
| Q4 2016 | $3,398,000 | -53.4% | 280,800 | -39.1% | 0.02% | -54.2% |
| Q3 2016 | $7,299,000 | +5.8% | 460,800 | -13.7% | 0.05% | +4.3% |
| Q2 2016 | $6,902,000 | +3.7% | 533,800 | +52.3% | 0.05% | +9.5% |
| Q1 2016 | $6,658,000 | -29.6% | 350,400 | -16.7% | 0.04% | -25.0% |
| Q4 2015 | $9,459,000 | +11.2% | 420,400 | +15.7% | 0.06% | +24.4% |
| Q3 2015 | $8,506,000 | -30.4% | 363,500 | -14.8% | 0.04% | -13.5% |
| Q2 2015 | $12,214,000 | +34.5% | 426,600 | +21.3% | 0.05% | +52.9% |
| Q1 2015 | $9,082,000 | +50.6% | 351,600 | +8.2% | 0.03% | +61.9% |
| Q4 2014 | $6,029,000 | +19.7% | 325,000 | 0.0% | 0.02% | +23.5% |
| Q3 2014 | $5,038,000 | – | 325,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|